Shares of Arena Pharmaceuticals rose 2.87% to $80.56 at 16:40 EST on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite is dropping 0.12% to $13,112.64, after two sequential sessions in a row of gains. This seems, so far, a somewhat negative trend exchanging session today.
Arena Pharmaceuticals’s last close was $78.31, 11.95% below its 52-week high of $90.19.
Arena Pharmaceuticals’s Sales
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Volatility
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.71%, 0.48%, and 0.59%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 7.15%, 4.71%, and 3.72%, respectively.
Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value
Arena Pharmaceuticals’s stock is valued at $80.56 at 16:40 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.
Arena Pharmaceuticals’s Moving Average
Arena Pharmaceuticals’s worth is way higher than its 50-day moving average of $72.38 and way higher than its 200-day moving average of $71.02.
